BRAF mutation analysis by ARMS-PCR refines thyroid nodule management
Clinical Endocrinology Aug 30, 2019
Li X, et al. - In a large fine-needle aspiration (FNA) cohort in China, researchers investigated the clinical significance of the BRAFV600E mutation on preoperative diagnosis and decision-making. This prospective study included 2,640 samples from 2,307 patients undergoing FNA procedures in a Chinese medical center. The data presented in this work showed a high mutation rate of 86.7% in the papillary thyroid carcinoma population. In young patients and patients with central lymph node metastasis, CT values of BRAFV600E of patients with PTMC were significantly lower. In BRAFV600E high-prevalence regions, including China, the combined analysis of cytological outcomes and BRAFV600E mutation is highly suggested. Regardless of the BRAF mutation status, prophylactic central neck dissection should be performed in selected patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries